Do current management strategies and guidelines adequately address fracture risk?
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Cost-Effectiveness of Alendronate Therapy for Osteopenic Postmenopausal WomenAnnals of Internal Medicine, 2005
- Hip Fracture in Women without OsteoporosisThe Journal of Clinical Endocrinology & Metabolism, 2005
- The impact of the use of multiple risk indicators for fracture on case-finding strategies: a mathematical approachOsteoporosis International, 2004
- Bone Mineral Density Thresholds for Pharmacological Intervention to Prevent FracturesArchives of internal medicine (1960), 2004
- American Association of Clinical Endocrinologists Medical Guidelines For Clinical Practice For The Prevention and Treatment of Postmenopausal Osteoporosis: 2001 Edition, With Selected Updates For 2003Endocrine Practice, 2003
- Treatment of postmenopausal osteoporosisThe Lancet, 2002
- Ten Year Probabilities of Osteoporotic Fractures According to BMD and Diagnostic ThresholdsOsteoporosis International, 2001
- Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical SynthesisJournal of Bone and Mineral Research, 2000
- Guidelines for diagnosis and management of osteoporosisOsteoporosis International, 1997
- Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fracturesBMJ, 1996